Steroids in malignant diseases: progress in patient selection.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000032:analysis / Q000188:drug therapy; D002460:Cell Line; D002478:Cells, Cultured; D004247:DNA / Q000378:metabolism; D004273:DNA, Neoplasm / Q000378:metabolism; D004347:Drug Interactions; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000188:drug therapy; D008214:Lymphocytes / Q000032:analysis; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*; D011965:Receptors, Glucocorticoid / Q000032:analysis / Q000187:drug effects* / Q000378:metabolism; D011987:Receptors, Steroid / Q000187:drug effects*
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D005938:Glucocorticoids; D011965:Receptors, Glucocorticoid; D011987:Receptors, Steroid; D004247:DNA